Wormser GP et al. Clinical Infectious Diseases 2006;43:1089-1134. Republished with permission from University of Chicago Press. © 2006 by the Infectious Diseases Society of America. All rights reserved.


Table Two: Recommended antimicrobial regimens for treatment of patients with Lyme disease.

DrugDosage for adultsDosage for children
Preferred oral regimens

     Amoxicillin500 mg 3 times per daya50 mg/kg per day in 3 divided doses (maximum, 500 mg per dose)a
     Doxycycline100 mg twice per daybNot recommended for children aged <8 years


For children aged ⩾8 years, 4 mg/kg per day in 2 divided doses (maximum, 100 mg per dose)
     Cefuroxime axetil500 mg twice per day30 mg/kg per day in 2 divided doses (maximum, 500 mg per dose)
Alternative oral regimens

     Selected macrolidescFor recommended dosing regimens, see footnote d in table 3For recommended dosing regimens, see footnote in table 3
Preferred parenteral regimen

     Ceftriaxone2 g intravenously once per day50–75 mg/kg intravenously per day in a single dose (maximum, 2 g)
Alternative parenteral regimens

     Cefotaxime2 g intravenously every 8 hd150–200 mg/kg per day intravenously in 3–4 divided doses (maximum, 6 g per day)d
     Penicillin G18–24 million U per day intravenously, divided every 4 hd200,000–400,000 U/kg per day divided every 4 hd (not to exceed 18–24 million U per day)

     a Although a higher dosage given twice per day might be equally as effective, in view of the absence of data on efficacy, twice-daily administration is not recommended.
     b Tetracyclines are relatively contraindicated in pregnant or lactating women and in children <8 years of age.
     c Because of their lower efficacy, macrolides are reserved for patients who are unable to take or who are intolerant of tetracyclines, penicillins, and cephalosporins.
     d Dosage should be reduced for patients with impaired renal function.